Filing Flows › Sanuwave Health (SNWV) › Q2 2026
Sanuwave Health (SNWV) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Sanuwave Health (SNWV) reported revenue of $9.7M for the second quarter 2026 (Q2 2026), -3% from a year earlier and +1% from the quarter before. Operating margin was -2.9%, net loss $682K (7.0% of revenue).
Sanuwave Health, Q2 2026: revenue $9.7M (-3% year over year), operating margin -2.9%, net loss $682K, operating cash flow $425K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.7M | +1% | -3% |
| Operating profit | −$280K | — | -115% |
| Net earnings | −$682K | — | -165% |
| Operating cash flow | $425K | +7% | -57% |
| Free cash flow | $91K | -76% | — |
What changed
Revenue was $9.7M in Q2 2026, down 3% year over year and up 1% from the previous quarter. Consumables, parts, and accessories revenue was the largest line at 75% of revenue. System revenue lost $1.2M year over year (down 34%), 367% of the total change.
Gross margin was 76.2%, down 1.8 points from Q2 2025. Operating costs exceeded revenue by $280K, an operating margin of -2.9%. Operating expenses grew 20% against a revenue fall of 3%. The fastest-growing cost line was Research & development (+224%). The quarter ended with a net loss of $682K, narrower than the previous quarter's $1.4M loss. Net interest and other expense of $396K was the main reason.
Operating cash flow was $425K (down 57% year over year). Non-cash charges added back $313K of depreciation and amortization and $1.5M of share-based compensation. Working capital and other items used $738K. Capital expenditures of $334K left free cash flow of $91K.
Questions
What was Sanuwave Health's revenue in the second quarter 2026?
Sanuwave Health (SNWV) reported revenue of $9.7M for the second quarter 2026 (Q2 2026), -3% from a year earlier and +1% from the quarter before.
Was Sanuwave Health profitable in the second quarter 2026?
Operating loss was $280K (-2.9% of revenue) and net loss $682K.
Source: Sanuwave Health 10-Q on SEC EDGAR.